F.D.A. Clears Pfizer’s Covid Pill for High-Risk Patients 12 and Oldernews2021-12-22T22:02:31+00:00December 22nd, 2021|The New York Times|
Pfizer’s Covid Pill Works Well, Company Confirms in Final Analysisnews2021-12-15T02:22:07+00:00December 15th, 2021|The New York Times|
Merck’s Covid Treatment Pill Wins Blessing of F.D.A. Panelnews2021-12-01T00:23:13+00:00December 1st, 2021|The New York Times|
Pfizer Asks F.D.A. to Authorize Its Covid-19 Vaccine for Children 5 to 11news2021-10-08T00:24:12+00:00October 8th, 2021|The New York Times|
Study: Pfizer Vaccine Protects Against Hospitalization for Six Monthsnews2021-10-04T22:30:04+00:00October 4th, 2021|The New York Times|
Why Covid Vaccines for Kids Are Taking the F.D.A. So Longnews2021-09-20T19:00:06+00:00September 20th, 2021|The New York Times|
Unvaccinated Americans Are 11 Times More Likely to Die of Covid, C.D.C. Reportsnews2021-09-10T21:12:49+00:00September 10th, 2021|The New York Times|
F.D.A. Fully Approves Pfizer Vaccinenews2021-08-24T00:07:03+00:00August 24th, 2021|The New York Times|
Covid Vaccines Produced in Africa Are Being Exported to Europenews2021-08-16T15:14:18+00:00August 16th, 2021|The New York Times|
